Patient-oriented and effectiveness research in chronic liver disease

慢性肝病的以患者为中心的有效性研究

基本信息

  • 批准号:
    8165204
  • 负责人:
  • 金额:
    $ 12.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-02 至 2017-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This is a K-24 ('Mid-career investigator Award in Patient-Oriented Research') application by W. Ray Kim, MD entitled, "Patient-Oriented and Effectiveness Research in Chronic Liver Disease." Chronic liver disease has a widespread health burden in the United States. It is the fourth most common cause of death in Americans aged between 41 and 50 years of age, indicating that it causes many premature deaths. Dr. Kim is one of the most productive researchers in patient-oriented research in liver disease. The most widely recognized achievement in Dr. Kim's research is the development, validation and refinement of the MELD score. He is also well known for his expertise in epidemiology, diagnosis, treatment and prevention of chronic viral hepatitis including hepatitis B and C. Since he joined the faculty at Mayo Clinic College of Medicine, he has led numerous research projects working with young investigators, many of whom continue their endeavors in academic medicine. He also organized educational programs in patient- oriented research methods on behalf of international academic societies. Dr. Kim's research program to date has been supported by three federal grants. The first grant continues to evaluate the MELD score and investigates chronic kidney disease in the setting of liver transplant candidates and recipients (R01). The second grant constitutes a pilot trial to test the hypothesis that nitric oxide plays an important role in post-transplant chronic kidney disease (R21). The third grant is a multicenter network to conduct research in hepatitis B (U01). In this application, Dr. Kim is requesting support of his time to mentor junior faculty members, fellows, residents and medical students working in patient oriented research. These mentees are mostly trainees at Mayo Clinic, but given the international background and reputation, selected individuals from institutions outside the US will also be included. Secondarily, the support will be used to enhance and supplement Dr. Kim's research expertise, specifically in the area of comparative effectiveness research and genetic epidemiology and bioinformatics. His mentoring plans include (1) formal methods training in patient-oriented research through the Center for Translational Science Activities (CTSA) and other didactic material at Mayo Clinic, (2) hands-on guidance for research experience in conducting individual projects, which includes study design, data collection and analysis, presentation and publication, and application for funding; and (3) one-on-one mentoring to accomplish career milestones in research from residency electives to fellowship training to junior faculty development. Strong Divisional and Institutional support exists to ensure the success of the mentoring program. PUBLIC HEALTH RELEVANCE: Chronic liver disease is one of the most common causes of premature death in Ameri- cans. Dr. Kim has been one of the most productive researchers in patient-oriented re- search in chronic liver disease. In this application, Dr. Kim is requesting support of his time to mentor junior faculty members, fellows, residents and medical students working in patient oriented research. The grant will also enhance and supplement Dr. Kim's re- search expertise, specifically in the area of comparative effectiveness research and ge- netic epidemiology and bioinformatics.
描述(由申请人提供):这是K-24(“以患者为导向研究的中期研究者奖”),由MD W. Ray Kim申请,标题为“慢性肝病中以患者为导向和有效性研究”。慢性肝病在美国具有广泛的健康负担。它是41至50岁的美国人中第四大死亡原因,表明它会导致许多过早死亡。 Kim博士是肝病研究中最有效的研究人员之一。 Kim博士的研究中最广泛认可的成就是MELD分数​​的开发,验证和完善。他还以在流行病学,诊断,治疗和预防慢性病毒肝炎(包括丙型肝炎)方面的专业知识而闻名。他加入了梅奥临床医学学院的教职员工,他领导了许多与年轻研究人员一起工作的研究项目,其中许多人继续从事学术医学的工作。他还代表国际学术社会组织了以患者为导向的研究方法的教育计划。迄今为止,金博士的研究计划得到了三项联邦赠款的支持。第一份赠款继续评估MELD评分,并在肝移植候选者和接受者的情况下研究慢性肾脏疾病(R01)。第二笔赠款构成了一项试验试验,以检验一氧化氮在移植后慢性肾脏疾病(R21)中起重要作用的假设。第三笔赠款是一个多中心网络,用于进行乙型肝炎(U01)研究。在此申请中,金博士要求支持他的时间指导初级教职员工,研究员,居民和医学生从事以患者为导向的研究。这些受训者主要是梅奥诊所的学员,但是鉴于国际背景和声誉,也将包括来自美国以外机构的精选个人。其次,该支持将用于增强和补充Kim博士的研究专业知识,特别是在比较有效性研究和遗传流行病学和生物信息学领域。他的指导计划包括(1)通过转化科学活动中心(CTSA)(CTSA)和Mayo Clinic的其他教学材料的正式方法培训,(2)进行单个项目的研究经验指南,其中包括研究设计,数据收集和分析,演示和分析,演示和出版,以及资金的应用; (3)一对一的指导,以实现从居住选修课到奖学金培训到初级教师发展的研究中的职业里程碑。存在强大的分区和机构支持,以确保指导计划的成功。 公共卫生相关性:慢性肝病是美国早期死亡最常见的原因之一。 Kim博士一直是慢性肝病中最有生产力的研究人员之一。在此申请中,金博士要求支持他的时间指导初级教职员工,研究员,居民和医学生从事以患者为导向的研究。该赠款还将增强和补充金博士的研究专业知识,特别是在比较有效性研究和网络流行病学和生物信息学领域。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

W. Ray KIM其他文献

W. Ray KIM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('W. Ray KIM', 18)}}的其他基金

Stratification of Non-alcoholic Fatty Liver Disease using the SAFE Score
使用 SAFE 评分对非酒精性脂肪肝进行分层
  • 批准号:
    10472578
  • 财政年份:
    2020
  • 资助金额:
    $ 12.68万
  • 项目类别:
Stratification of Non-alcoholic Fatty Liver Disease using the SAFE Score
使用 SAFE 评分对非酒精性脂肪肝进行分层
  • 批准号:
    10101509
  • 财政年份:
    2020
  • 资助金额:
    $ 12.68万
  • 项目类别:
Stratification of Non-alcoholic Fatty Liver Disease using the SAFE Score
使用 SAFE 评分对非酒精性脂肪肝进行分层
  • 批准号:
    10264889
  • 财政年份:
    2020
  • 资助金额:
    $ 12.68万
  • 项目类别:
Patient-oriented and effectiveness research in chronic liver disease
慢性肝病的以患者为中心的有效性研究
  • 批准号:
    8909785
  • 财政年份:
    2012
  • 资助金额:
    $ 12.68万
  • 项目类别:
Patient-oriented and effectiveness research in chronic liver disease
慢性肝病的以患者为中心的有效性研究
  • 批准号:
    8471698
  • 财政年份:
    2012
  • 资助金额:
    $ 12.68万
  • 项目类别:
Patient-oriented and effectiveness research in chronic liver disease
慢性肝病的以患者为中心的有效性研究
  • 批准号:
    8719982
  • 财政年份:
    2012
  • 资助金额:
    $ 12.68万
  • 项目类别:
Optimal Long-term Outcome of Chronic Hepatitis B
慢性乙型肝炎的最佳长期结果
  • 批准号:
    8139765
  • 财政年份:
    2008
  • 资助金额:
    $ 12.68万
  • 项目类别:
L-arginine supplement for the prevention of calcineurin inhibitor nephrotoxicity
L-精氨酸补充剂用于预防钙调神经磷酸酶抑制剂肾毒性
  • 批准号:
    8217686
  • 财政年份:
    2008
  • 资助金额:
    $ 12.68万
  • 项目类别:
Optimal Long-term Outcome of Chronic Hepatitis B
慢性乙型肝炎的最佳长期结果
  • 批准号:
    7693846
  • 财政年份:
    2008
  • 资助金额:
    $ 12.68万
  • 项目类别:
L-arginine supplement for the prevention of calcineurin inhibitor nephrotoxicity
L-精氨酸补充剂用于预防钙调神经磷酸酶抑制剂肾毒性
  • 批准号:
    7469314
  • 财政年份:
    2008
  • 资助金额:
    $ 12.68万
  • 项目类别:

相似国自然基金

无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
  • 批准号:
    62372118
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
  • 批准号:
    82300679
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
  • 批准号:
    82301784
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
  • 批准号:
    82301217
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
  • 批准号:
    82373667
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

The Potential of a Universal Basic Income for Justice-Involved Black Men at Historical Colleges and Universities under the Second Chance Pell Experimental Site Initiative
在第二次机会佩尔实验点倡议下,历史学院和大学中涉及正义的黑人获得普遍基本收入的潜力
  • 批准号:
    10854420
  • 财政年份:
    2022
  • 资助金额:
    $ 12.68万
  • 项目类别:
PRECISE - a PErsonalized Risk Score for gastrIc CancEr
PRECISE - 胃癌的个性化风险评分
  • 批准号:
    10550247
  • 财政年份:
    2021
  • 资助金额:
    $ 12.68万
  • 项目类别:
The eXtraordinarY Babies Study: Natural History of Health and Neurodevelopment in Infants and Young Children with Sex Chromosome Trisomy
非凡婴儿研究:性染色体三体婴幼儿健康和神经发育的自然史
  • 批准号:
    10011576
  • 财政年份:
    2017
  • 资助金额:
    $ 12.68万
  • 项目类别:
The eXtraordinarY Babies Study: Natural History of Health and Neurodevelopment in Infants and Young Children with Sex Chromosome Trisomy
非凡婴儿研究:性染色体三体婴幼儿健康和神经发育的自然史
  • 批准号:
    10228690
  • 财政年份:
    2017
  • 资助金额:
    $ 12.68万
  • 项目类别:
Access to Community Based Palliative Care among Medically-Underserved Older Adults
医疗服务不足的老年人获得社区姑息治疗的机会
  • 批准号:
    9756415
  • 财政年份:
    2017
  • 资助金额:
    $ 12.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了